Kelly Lyons

1.0k total citations
12 papers, 742 citations indexed

About

Kelly Lyons is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kelly Lyons has authored 12 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 4 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kelly Lyons's work include Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological diseases and metabolism (2 papers). Kelly Lyons is often cited by papers focused on Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological diseases and metabolism (2 papers). Kelly Lyons collaborates with scholars based in United States and France. Kelly Lyons's co-authors include William C. Koller, Rajesh Pahwa, Erwin B. Montgomery, Alexander I. Tröster, Kenneth B. Baker, John Overman, Sharon Pickering, Steven B. Wilkinson, Mary A. Carpenter and Jeff Searl and has published in prestigious journals such as Neurology, Movement Disorders and Parkinsonism & Related Disorders.

In The Last Decade

Kelly Lyons

12 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Lyons United States 8 340 201 178 53 53 12 742
Hye Mi Lee South Korea 18 381 1.1× 129 0.6× 319 1.8× 30 0.6× 80 1.5× 39 1.1k
Tanguy Chaumette France 13 625 1.8× 164 0.8× 260 1.5× 23 0.4× 150 2.8× 16 1.1k
Itzhak Wirguin Israel 21 499 1.5× 222 1.1× 389 2.2× 15 0.3× 101 1.9× 49 1.3k
Jorge Rubén Cabrera Spain 17 133 0.4× 317 1.6× 435 2.4× 20 0.4× 112 2.1× 26 853
M. Fiori Italy 18 201 0.6× 267 1.3× 244 1.4× 35 0.7× 276 5.2× 88 1.0k
Norihiro Matsuoka Japan 10 149 0.4× 154 0.8× 211 1.2× 25 0.5× 176 3.3× 18 1.1k
Gabriela Mercado United States 14 472 1.4× 260 1.3× 416 2.3× 22 0.4× 233 4.4× 23 1.2k
Argelia E. Rojas-Mayorquín Mexico 12 98 0.3× 140 0.7× 186 1.0× 28 0.5× 90 1.7× 22 568
Bryan A. Killinger United States 20 402 1.2× 210 1.0× 413 2.3× 14 0.3× 206 3.9× 25 943
D. Colette Williams United States 18 90 0.3× 91 0.5× 196 1.1× 60 1.1× 47 0.9× 44 750

Countries citing papers authored by Kelly Lyons

Since Specialization
Citations

This map shows the geographic impact of Kelly Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Lyons more than expected).

Fields of papers citing papers by Kelly Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Lyons. The network helps show where Kelly Lyons may publish in the future.

Co-authorship network of co-authors of Kelly Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Lyons. A scholar is included among the top collaborators of Kelly Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Lyons. Kelly Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Sharma, Vibhash D., Kelly Lyons, & Rajesh Pahwa. (2018). Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease. Therapeutics and Clinical Risk Management. Volume 14. 665–673. 33 indexed citations
3.
Pahwa, Rajesh, W. Poewe, Kelly Lyons, & Babak Boroojerdi. (2009). P2.152 Changes in early-morning motor status following adjunctive treatment of advanced Parkinson's disease with rotigotine transdermal system: two large, placebo-controlled trials. Parkinsonism & Related Disorders. 15. S130–S131. 5 indexed citations
4.
Gurevich, V. A., Joseph Bertolini, & Kelly Lyons. (2006). Determination of Fc function with frozen red blood cells. Biologicals. 34(3). 221–222. 2 indexed citations
5.
Lieberman, Abraham, Kelly Lyons, Jay F. Levine, & Robert J. Myerburg. (2005). Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease. Parkinsonism & Related Disorders. 11(2). 81–84. 32 indexed citations
6.
Koller, William C., et al.. (2002). Mechanism of Action. 333 indexed citations
7.
Montgomery, Erwin B., Kelly Lyons, & William C. Koller. (2000). Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery. Movement Disorders. 15(3). 474–478. 48 indexed citations
8.
Montgomery, Erwin B., et al.. (2000). Early detection of probable idiopathic Parkinson's disease: I. development of a diagnostic test battery. Movement Disorders. 15(3). 467–473. 52 indexed citations
9.
Pahwa, Rajesh, Kelly Lyons, Steven B. Wilkinson, et al.. (1999). Bilateral thalamic stimulation for the treatment of essential tremor. Neurology. 53(7). 1447–1447. 104 indexed citations
10.
Montgomery, Erwin B., Kenneth B. Baker, Kelly Lyons, & William C. Koller. (1999). Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology. 52(4). 757–757. 63 indexed citations
11.
Wilkinson, Steve, William C. Koller, Rajesh Pahwa, et al.. (1998). Lesion Volume and Clinical Outcome in Stereotactic Pallidotomy and Thalamotomy. Stereotactic and Functional Neurosurgery. 71(4). 164–172. 7 indexed citations
12.
Miyawaki, Edison, Kelly Lyons, Rajesh Pahwa, et al.. (1997). Motor Complications of Chronic Levodopa Therapy in Parkinsonʼs Disease. Clinical Neuropharmacology. 20(6). 523–530. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026